Akari Therapeutics PLC (AKTX)
0.97
-0.03
(-2.99%)
USD |
NASDAQ |
Dec 20, 16:00
0.95
-0.02
(-2.06%)
After-Hours: 20:00
Akari Therapeutics Total Liabilities (Quarterly): 9.428M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| DBV Technologies SA | 39.02M |
| Ascendis Pharma AS | 1.330B |
| Cellectis SA | 266.45M |
| Adaptimmune Therapeutics PLC | 237.45M |
| Biodexa Pharmaceuticals PLC | 6.628M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.734M |
| Shareholders Equity (Quarterly) | -6.694M |